Covid-19 News

    Quote from Fm1

    Given that youth don’t tend to get very sick from this pandemic

    1.8% of the youth have long COVID symptoms lasting more than 8 weeks


    Long-term cognitive deficits have not been studied in children, but whole population average cognitive deficits are real (= very common), so it would be surprising if there were not a risk at 1:10,000 level or worse in children


    The vaccine side effects are much less of a risk than COVID on this evidence, and certainly the covid risks are more concerning, because less studied.


    Where is that careful risk analysis and comparison in these breezy opinion articles? It is very irresponsible to minimise one side of the risk.

    The TSN editorials on vaccine risk are so one-sided! I'm willing to bet they will not link this!


    Myocarditis age 12-17 is six times higher after COVID than after vaccine.

    Myocarditis is more common after covid-19 infection than vaccination
    A preliminary study suggests that, among those most likely to develop myocarditis, the heart condition is six times more likely to occur after having covid-19…
    www.newscientist.com



    Now a study in the US has analysed how often myocarditis occurs following infection with the coronavirus. Researchers analysed the records of healthcare organisations that cover a fifth of the US population. They found that, during the first 12 months of the pandemic, males aged 12 to 17 were most likely to develop myocarditis within three months of catching covid-19, at a rate of about 450 cases per million infections.

    This compares with 67 cases of myocarditis per million males of the same age following their second dose of a Pfizer/BioNTech or Moderna vaccine, according to figures from the US Advisory Committee on Immunization Practices. Researchers added together cases after first and second doses to reach a total rate of 77 cases per million in this male age group triggered by vaccination, a sixth that seen after infection.


    The small risk of myocarditis after the Pfizer/BioNTech vaccine is one reason why the UK’s Joint Committee on Vaccination and Immunisation (JCVI) hasn’t yet recommended this vaccine – the only one licensed for use in under-18s in the UK – for most children aged 12 and over. While countries such as Ireland and the US are letting teenagers get vaccinated, the JCVI said in July that only younger people who are highly vulnerable or living with someone with a weak immune system could have the jab.


    Iacob says people who have been vaccinated or had covid-19 should be aware of possible symptoms of myocarditis, especially chest pain that is burning or sharp and worsens on changing position.


    Study results


    In the 12-17 years age group, about 0.09% of male COVID-19 patients were diagnosed with myocarditis. This corresponded to a rate of 876 myocarditis cases per million male COVID-19 patients. After adjusting for missed COVID-19 cases, an incidence rate of 450 myocarditis cases per million patients was estimated.


    Similarly, for the 12-15 and 16-19 age groups, the adjusted myocarditis cases per million patients were estimated to be 601 and 561, respectively.


    In female COVID-19 patients belonging to the age groups of 12-17 years, 12-15 years, and 16-19, the adjusted rates of myocarditis per million patients were estimated to be 213, 235, and 708, respectively.

    By considering the entire study population, including males and females, the adjusted rates of myocarditis per million patients were estimated to be 328, 416, and 643 for the 12-17 years, 12-15 years, and 16-19 years age groups, respectively.

    Of all identified myocarditis cases, about 40% occurred within 5 days and 60% occurred within 19 to 82 days following COVID-19 diagnosis.


    In this risk balance for anyone > 12 years, the one thing not well studied is for those who have already had COVID. Vaccination will then increase immunity against re-infection, and the COVID risks in that case must be smaller, so for young children maybe the balance would be not to vaccinate? I would not be confident to say one way or the other without good data, which we do not have.


    THH

    Quote from THHuxleynew

    within three months of catching covid-19, at a rate of about 450 cases per million infections

    So we have myocarditis 2 weeks after vaccination 60/mio and three months after getting CoV-19 (450/mio). I guess after a short refresh of undergrad math you will see the problem...


    May be you should also report the death numbers from myocarditis...that are far more interesting among age 18..55...

    Quote from Wyttenbach

    Would it more clear to say that in USA so far about 20 kids have been killed by the CoV-19 gen therapy??

    Even if we ignore the gen therapy misstatement, it would be more clear, and also more wrong. Data please, with links, and I will tell you why you got it wrong. It would however be correct to say that 325 child deaths have occurred from COVID in the US.


    Of the almost 600,000 deaths attributed to COVID-19 in the United States in just over 17 months, about 325 have been people under the age of 18, according to the Centers for Disease Control and Prevention (CDC)

    . The CDC also reports that hospitalization rates are lower for children and adolescents than for adults, the CDC reports.


    But in the context of diseases associated with children, COVID-19 causes more deaths and hospitalizations than several viral diseases that have been deemed severe enough to prompt the development of vaccines (such as chickenpox), and it appears to be surpassing the flu. Children’s hospitalization rates for COVID-19 “are in the range … of what we see for influenza in any given season,” Evan Anderson, MD, an associate professor of pediatrics at Emory University School of Medicine in Atlanta, reported in a recent webinar

    hosted by the American College of Medical Toxicology.


    The flu typically kills about 100 children a year, with totals ranging from 39 to 199 in recent years

    , according to the CDC. At current rates, child deaths related to COVID-19 stand at more than 200 a year.


    Evidence is also emerging about the long-term effects of COVID-19 on young people, including fatigue, headaches, and loss of the sense of taste or smell for months, as well as long-term brain loss

    . A study in the United Kingdom

    found that “it is becoming increasingly apparent that a large number of children with symptomatic and asymptomatic COVID-19 are experiencing long-term effects, many months after the initial infection.”





    Quote from Wyttenbach

    Gen therapy a word all FUD'rs here don't like

    Gen therapy sounds like a 2000s band name!, or possibly a holistic new wave treatment for feeling low.


    But it has no relation to mRNA vaccines so using it as this is incorrect, and misleading.

    Quote from Wyttenbach

    May be you should also report the death numbers from myocarditis...that are far more interesting among age 18..55...

    I thought we were comparing with vaccines? There are no vaccine myocarditis deaths for children, nor AFAIK any COVID ones. However there is a significant likelihood of MIS-C - like myocarditis but much more serious - from COVID for children.


    Why are you changing the topic - we were looking at comparison of COVID and vaccine for children age 12-17.


    Of course more children die from COVID, the point is that even with this most common serious vaccine side effect, it is much more likely after COVID than after vaccination.

    Quote from THHuxleynew

    I thought we were comparing with vaccines?

    Go on. Compare healthy and fit low BMI adults (US army .5 mio male) vaccinated age 18..55 with a similar group.

    We don't have any data (1 mio needed!) from children age 12..17 so far. May be you as an insider got some early briefing... Deaths usually are reported with a time lag > 2 months...If ever...Pfizer pays a lot for shutting up...

    Quote from THHuxleynew

    It would however be correct to say that 325 child deaths have occurred from COVID in the US.

    We discussed this a long time ago almost all on leukemia chemo . Poor kids, got it at the wrong time and had no chance. But also any flu would have killed them.

    So we here discuss about healthy people age <65 in general that need no vaccine at all.

    University of Manitoba Participates in Two Studies Indicating Full Dose Blood Thinners Benefit Moderately Ill COVID-19 Patients


    University of Manitoba Participates in Two Studies Indicating Full Dose Blood Thinners Benefit Moderately Ill COVID-19 Patients
    The use of heparin (a blood thinner) in hospitalized patients with COVID-19 improves survival and reduces the need for vital organ support such as
    trialsitenews.com


    The use of heparin (a blood thinner) in hospitalized patients with COVID-19 improves survival and reduces the need for vital organ support such as mechanical ventilation in moderately ill patients but doesn’t yield the same positive outcomes among critically ill patients already requiring life support. This conclusion is based on two Canadian-led clinical trials published on August 4th in the New England Journal of Medicine.


    These collaborative international clinical trials tested full-dose anticoagulation, titled Therapeutic Anticoagulation with Heparin in Noncritically Ill Patients with Covid-19 and Therapeutic Anticoagulation with Heparin in Critically Ill Patients with Covid-19. Dr. Ryan Zarychanski, associate professor of internal medicine, University of Manitoba, and hematologist, critical care physician and senior scientist at CancerCare Manitoba, Canada, shared in the University of Manitoba news, “We had an unprecedented opportunity to work with colleagues across Canada, the United States and around the world to test the benefit of full-dose blood thinners on hospitalized COVID-19 patients. Therapeutic heparin improved survival and decreased progression to severe disease, thus reducing the pressure on intensive care units globally.”


    The Background

    Early in the pandemic, physicians around the world observed increased rates of blood clots and inflammation among COVID-19 patients, which affected multiple organs and led to complications such as lung failure, heart attack, and stroke. Whether providing increased doses of blood thinners routinely administered to hospitalized patients would be safe and effective was unknown at that time.


    Participating Trial Platforms

    The participating trial platforms that contributed to the global trial were Antithrombotic Therapy to Ameliorate Complications of COVID-19 (ATTACC); Randomized, Embedded, Multi-factorial Adaptive Platform Trial for Community-Acquired Pneumonia (REMAP-CAP); and Accelerating COVID-19 Therapeutic Interventions and Vaccines-4 (ACTIV-4) platforms.


    The Study

    The worldwide, multi-platform trial spanned five continents in over 300 hospitals to test blood thinners on both sets of patients.


    “The goal [of our trials] was to improve survival and prevent patients from requiring ICU-level care or developing multi-organ failure,” said Dr. Patrick Lawler, cardiologist at the University of Toronto and Peter Munk Cardiac Centre at University Health Network. He was co-principal investigator of ATTACC, a member of the international trial steering committee for REMAP-CAP, and on the ACTIV-4a protocol development committee.


    In December 2020, results indicated that full-dose anticoagulation with heparin was not beneficial and appeared to be harmful among critically ill patients – but the findings were completely different in non-critically ill patients. In January 2021, results of the treatment among moderately ill COVID patients showed full doses of heparin reduced the need for life support with improved survival.


    Moderately ill patients are defined as hospitalized COVID-19 patients who were not in ICU and not receiving organ support such as mechanical ventilation at trial enrollment.


    The trial involved 1,074 critically ill and 2,219 moderately ill patients. Physician investigators gauged how long participants were free of organ support up to 21 days after enrolling in the clinical trial. The investigators discovered that in moderately ill patients, full-dose heparin reduced the need for organ support compared to those who received lower-dose heparin. By contrast, full-dose heparin was associated with a high probability of a worse outcome for critically ill patients.


    New ‘Standard of Care’

    “Our conclusions have set a new standard of care for moderately ill hospitalized COVID-19 patients around the world using an affordable, accessible, and familiar drug. As such, the results of the trial can be immediately applied,” said Dr. Ewan Goligher, critical care physician and scientist at Toronto General Hospital, co-chair of the therapeutic anticoagulation domain in REMAP-CAP and co-principal investigator of the ATTACC platform.


    “While the trial results will immediately impact care around the world, it is the methods of collaboration created that will be an enduring contribution of this first of a kind clinical trial that paves the way for future multiplatform clinical trial collaborations on a global scale,” said Zarychanski, senior author, chair of the ATTACC trial and the REMAP-CAP anticoagulation domain and member of the ACTIV-4a protocol development committee.


    “We were excited to provide leadership on these innovative, large scale clinical trials – especially at a critical time during the COVID-19 pandemic – and our findings demonstrate the value of international multiplatform collaboration and the future possibilities for continuing to study ways to improve health outcomes in COVID-19 and possibly other diseases,” said Lawler.


    “It is a testament to the dedication of researchers around the world who worked closely and collaboratively during a very difficult time that we were able to discover a treatment that can prevent patients from becoming severely ill and improve their recovery and outcomes, but our work is not over yet,” added Goligher.


    “The Manitoba government is proud to have been an early supporter of this ground-breaking, life-saving research led out of our province,” Manitoba Premier Brian Pallister said. “The $5 million COVID-19 research fund announced last spring through Research Manitoba allowed local clinician-scientists to embed clinical trials into clinical care and collaborate in new ways so that their research findings can have global impact by advancing COVID-19 treatments.”


    Funding Support

    In Canada, the trials were supported by multiple international funding organizations, including the Canadian Institutes of Health Research (CAN), LifeArc, the Provinces of Ontario and Manitoba, the Peter Munk Cardiac Centre, the Thistledown Foundation, CancerCare Manitoba Foundation, and the Victoria General Hospital Foundation. Trial management and data coordination were provided by Ozmosis Research and Socar Research. Internationally, the trials were supported by the NIH National Heart, Lung & Blood Institute, Translational Breast Cancer Research Consortium and the UPMC Learning While Doing Program (US), National Institute for Health Research (UK), National Health and Medical Research Council (AUS), Health Research Council of New Zealand, and the PREPARE and RECOVER consortia (EU).

    Quote from THHuxleynew

    Gen therapy sounds like a 2000s band name!, or possibly a holistic new wave treatment for feeling low.


    But it has no relation to mRNA vaccines so using it as this is incorrect, and misleading.

    The same= identical therapy is use against cancer since more than 10 years now. There it's called gen therapy. So please ask Roche to rebrand it as cancer vaccine...

    Quote from Zeus46

    Its a great shame that bullshitting isn’t an olympic sport, as Switzerland would likely have tripled their paltry medal tally on the last couple of days action


    Let’s have a look at the link provided, shall we?


    “In 128 serious cases, the people concerned died at differing intervals after receiving the vaccine. Despite a chronological correlation, there is no concrete evidence to suggest that the vaccination was the cause of death.”

    No reason to become inpolite!


    I don't see any reason why this cannot be true.

    I can provide the official statistics from Austria which is of similar population size like Switzerland. We had unfortunatley so far (27.12.20 - 28.7.21) 151 death "...in close temporal vicinty of vaccination..."

    Report of BASG (Federal office for safety in healthcare) only issued in German! Refer to page 6!

    Quote from Wyttenbach

    We discussed this a long time ago almost all on leukemia chemo . Poor kids, got it at the wrong time and had no chance. But also any flu would have killed them.

    So we here discuss about healthy people age <65 in general that need no vaccine at all.

    No, we were discussing kids 12-17. And since most of your statements here are false I will not accept the almost all on leukemia chemo one.


    Your mantra of healthy people <65. Like me. You are wrong that they have no risk. They have less risk than those of same age with comorbidities, but it would be very strange if they had no risk. The risk increase for those with comorbidities is not that high. Since a large risk component is immune system interaction with COVID you'd expect healthy risk to be not that different from average for age and sex risk.


    So, like zeuss I'm a bit bored at the repeated unevidenced false statements you make. Try posting evidence. Like I do. It is not difficult. If your statements are true.

    Quote from gerold.s

    I don't see any reason why this cannot be true.

    I can provide the official statistics from Austria which is of similar population size like Switzerland. We had unfortunatley so far (27.12.20 - 28.7.21) 151 death "...in close temporal vicinty of vaccination..."

    The big anti-vax lie is to conflate in close temporal vicinity with causal. There is a high background rate of death (people, esp older people, die) and you need to eliminate that. The overall figures are mostly/all (depending) background rate.


    W knows this - the deceit comes from not acknowledging this issue and how it completely changes the numbers.

    Quote from THHuxleynew

    Your mantra of healthy people <65. Like me. You are wrong that they have no risk.

    I agree that live is a risk. But for healthy people age < 65 CoV-19 does add nothing of significance.

    Study the links I gave. Below age 50 the mortality here is far lower that for e.g. soap slipping... or car accidents or classic heart/brain strokes...And this link shows all deaths with no comorbidity.

    The avg. age of hospitalization here is just 5 years lower now. Most among people with 2 risks at least, that so far had no RNA therapy, albeit they should have had one if they don't know the early treatment.


    So please stop your (pseudo vaccine) gen therapy commercials...

    Healthy people age < 65 don't need it. You still can say that in some rare cases some people do not know that they are sick and thus do have a high CoV-19 risk. But that's live... Overall - group wide - risks from the therapy are much higher.

Subscribe to our newsletter

It's sent once a month, you can unsubscribe at anytime!

View archive of previous newsletters

* indicates required

Your email address will be used to send you email newsletters only. See our Privacy Policy for more information.

Our Partners

Supporting researchers for over 20 years
Want to Advertise or Sponsor LENR Forum?
CLICK HERE to contact us.